Allstate Corporation’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.7M | Buy |
56,015
+15,889
| +40% | +$5.66M | 0.21% | 63 |
|
|
2025
Q4 | $13.1M | Buy |
40,126
+20,511
| +105% | +$6.51M | 0.18% | 74 |
|
|
2025
Q3 | $5.54M | Buy |
19,615
+18,509
| +1,674% | +$5.37M | 0.13% | 87 |
|
|
2025
Q2 | $309K | Sell |
1,106
-17,272
| -94% | -$4.89M | 0.02% | 119 |
|
|
2025
Q1 | $5.73M | Buy |
18,378
+2,430
| +15% | +$718K | 0.17% | 72 |
|
|
2024
Q4 | $4.16M | Buy |
+15,948
| New | +$4.73M | 0.12% | 94 |
|
|
2024
Q3 | – | Sell |
-1,774
| Closed | -$554K | – | 115 |
|
|
2024
Q2 | $554K | Sell |
1,774
-5
| -0.3% | -$1.47K | 0.05% | 102 |
|
|
2024
Q1 | $506K | Sell |
1,779
-6
| -0.3% | -$1.76K | 0.04% | 113 |
|
|
2023
Q4 | $514K | Sell |
1,785
-29
| -2% | -$7.9K | 0.04% | 102 |
|
|
2023
Q3 | $488K | Hold |
1,814
| – | – | 0.03% | 106 |
|
|
2023
Q2 | $403K | Buy |
1,814
+39
| +2% | +$9.05K | 0.03% | 129 |
|
|
2023
Q1 | $429K | Sell |
1,775
-23,585
| -93% | -$5.79M | 0.03% | 119 |
|
|
2022
Q4 | $6.66M | Buy |
25,360
+279
| +1% | +$74.8K | 0.2% | 69 |
|
|
2022
Q3 | $5.65M | Sell |
25,081
-230
| -0.9% | -$55.8K | 0.16% | 76 |
|
|
2022
Q2 | $6.16M | Sell |
25,311
-7,760
| -23% | -$1.9M | 0.19% | 68 |
|
|
2022
Q1 | $8M | Sell |
33,071
-4,494
| -12% | -$1.03M | 0.21% | 62 |
|
|
2021
Q4 | $8.45M | Buy |
37,565
+25,726
| +217% | +$5.43M | 0.16% | 100 |
|
|
2021
Q3 | $2.52M | Sell |
11,839
-1,334
| -10% | -$307K | 0.1% | 96 |
|
|
2021
Q2 | $3.21M | Sell |
13,173
-1,186
| -8% | -$292K | 0.11% | 78 |
|
|
2021
Q1 | $3.57M | Buy |
14,359
+1,143
| +9% | +$273K | 0.11% | 77 |
|
|
2020
Q4 | $3.04M | Sell |
13,216
-588
| -4% | -$136K | 0.09% | 73 |
|
|
2020
Q3 | $3.51M | Sell |
13,804
-2,891
| -17% | -$716K | 0.11% | 59 |
|
|
2020
Q2 | $3.94M | Sell |
16,695
-1,264
| -7% | -$288K | 0.14% | 59 |
|
|
2020
Q1 | $3.64M | Sell |
17,959
-37,080
| -67% | -$8.1M | 0.14% | 54 |
|
|
2019
Q4 | $13.3M | Buy |
55,039
+597
| +1% | +$132K | 0.24% | 46 |
|
|
2019
Q3 | $10.5M | Buy |
54,442
+13,541
| +33% | +$2.6M | 0.18% | 56 |
|
|
2019
Q2 | $7.54M | Sell |
40,901
-34,925
| -46% | -$6.25M | 0.13% | 78 |
|
|
2019
Q1 | $14.4M | Buy |
75,826
+142
| +0.2% | +$27.1K | 0.39% | 39 |
|
|
2018
Q4 | $14.7M | Buy |
75,684
+74,705
| +7,631% | +$14.6M | 0.48% | 32 |
|
|
2018
Q3 | $203K | Buy |
+979
| New | +$193K | 0.01% | 41 |
|
|
2017
Q3 | – | Sell |
-19,657
| Closed | -$3.39M | – | 39 |
|
|
2017
Q2 | $3.39M | Buy |
19,657
+3,328
| +20% | +$541K | 0.18% | 44 |
|
|
2017
Q1 | $2.68M | Sell |
16,329
-55,501
| -77% | -$9.22M | 0.16% | 90 |
|
|
2016
Q4 | $10.5M | Buy |
71,830
+35,423
| +97% | +$5.33M | 0.63% | 37 |
|
|
2016
Q3 | $6.07M | Buy |
36,407
+6,967
| +24% | +$1.18M | 0.43% | 38 |
|
|
2016
Q2 | $4.48M | Buy |
29,440
+2,221
| +8% | +$345K | 0.29% | 86 |
|
|
2016
Q1 | $4.08M | Sell |
27,219
-250
| -0.9% | -$37.1K | 0.35% | 93 |
|
|
2015
Q4 | $4.46M | Buy |
+27,469
| New | +$4.32M | 0.42% | 62 |
|
|
2015
Q3 | – | Sell |
-28,940
| Closed | -$4.44M | – | 210 |
|
|
2015
Q2 | $4.44M | Sell |
28,940
-2,799
| -9% | -$448K | 0.4% | 60 |
|
|
2015
Q1 | $5.07M | Buy |
31,739
+2,359
| +8% | +$372K | 0.42% | 63 |
|
|
2014
Q4 | $4.68M | Sell |
29,380
-4,574
| -13% | -$713K | 0.36% | 90 |
|
|
2014
Q3 | $4.77M | Buy |
+33,954
| New | +$4.43M | 0.22% | 159 |
|
Other funds holding AMGN
VCM
VPM
Allstate Corporation's AMGN Position: Q1 2026 in Review
Allstate Corporation increased its Amgen (AMGN) stake by 40% in Q1 2026, buying an estimated $5.66M and bringing the position to 56,015 shares worth $19.7M. The position accounts for 0.21% of the portfolio, ranked #63.
Allstate Corporation first reported a position in AMGN in Q3 2014 and has held it in 41 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Allstate Corporation held 56,015 shares of Amgen worth $19.7M as of Q1 2026.
- Allstate Corporation bought 15,889 Amgen shares in Q1 2026, an estimated $5.66M.
- Amgen made up 0.21% of Allstate Corporation's portfolio in Q1 2026, its #63 holding.
- Allstate Corporation first reported a position in Amgen in Q3 2014 and has held it in 41 quarters since.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.